Bill Summary
HB 885 Prescription Drugs Used in the Treatment of Schizophrenia for Medicaid Recipients (2022 Session)
Prescription Drugs Used in the Treatment of Schizophrenia for Medicaid Recipients: Authorizes approval of drug products or certain medication prescribed for treatment of schizophrenia or schizotypal or delusional disorders for Medicaid recipients who have not met step-therapy prior authorization criteria under certain circumstances. Effective Date: July 1, 2022
12/09/21
HOUSE
Filed
01/03/22
HOUSE
Referred to Finance & Facilities Subcommittee; Health Care Appropriations Subcommittee; Health & Human Services Committee
01/03/22
HOUSE
Now in Finance & Facilities Subcommittee
02/04/22
HOUSE
On Committee agenda - Finance & Facilities Subcommittee, 02/08/22, 1:00 pm, 17 H
02/08/22
HOUSE
Favorable by Finance & Facilities Subcommittee; 15 Yeas, 0 Nays
02/08/22
HOUSE
Now in Health Care Appropriations Subcommittee
02/10/22
HOUSE
On Committee agenda - Health Care Appropriations Subcommittee, 02/14/22, 1:30 pm, 17 H
02/14/22
HOUSE
Favorable by Health Care Appropriations Subcommittee; 12 Yeas, 0 Nays
02/14/22
HOUSE
Now in Health & Human Services Committee
02/21/22
HOUSE
On Committee agenda - Health & Human Services Committee, 02/23/22, 9:00 am, 17 H
02/23/22
HOUSE
Favorable by Health & Human Services Committee; 17 Yeas, 0 Nays
02/23/22
HOUSE
Placed on Calendar, on 2nd reading
02/28/22
HOUSE
Placed on Special Order Calendar, 03/03/22
03/03/22
HOUSE
Read Second Time; Substituted for SB 0534; Laid on Table, Refer to SB 0534
No amendments to this bill text filed.
409.912
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.
No reports related to this bill.
Upcoming Events
Florida's most comprehensive legislative calendar.
Learn more.
No events are scheduled at this time.
Press Releases
Related Press Announcements. Learn more.
No press releases related to this bill.
Features above are available to LobbyTools subscribers.
Request a free demo or call (850) 915-0100 ext. 2 to learn more.